• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Linus Health Launches AI Platform to Detect, Delay Dementia

by Syed Hamza Sohail 07/28/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Linus Health Launches AI Platform to Detect, Delay Dementia

What You Should Know:

– Linus Health launches the first iPad-based cognitive screening platform able to detect cognitive decline such as dementia years before the human eye could ever do so.

– Linus is now offering a solution to empower PCPs to not only pinpoint cognitive issues in just minutes but also leverage AI to provide patients with evidence-based early interventions

IPad-Based Brain Health Platform

Projections estimate that the number of people in the US with Alzheimer’s disease and other dementias will more than double over the next 30 years – from 6M to almost 13M – as the population ages. The expected rise in brain disorders amplifies the need for timely detection and intervention – a key driver behind Linus Health’s mission

Linus Health has announced that its groundbreaking brain health platform is generally available for healthcare delivery organizations across the US. Designed to facilitate early detection of brain disorders and proactive intervention, the SaaS-based platform combines robust digital cognitive assessments with actionable recommendations for providers and patients. Given the growing role primary care providers (PCPs) will play in getting ahead of brain disorders, the platform was purpose-built to expand brain care delivery in primary care while streamlining PCP workflows.

The new platform incorporates and expands on Linus Health’s DCTclock, an iPad-based, AI-enhanced version of the long-standing paper-based Clock Drawing Test. Unique in its use of AI to analyze both a patient’s final clock drawings and their drawing process, DCTclock delivers greater sensitivity than traditional cognitive tests and earned recognition on TIME’s 100 Best Inventions of 2021 list.  Furthermore, The Davos Alzheimer’s Collaborative, an organization leading an unprecedented global response to Alzheimer’s disease, recently launched an initiative to expand early detection of Alzheimer’s with more proactive, innovative screenings. Four of the seven flagship sites involved chose Linus’ solution.

“With the strain on specialists only rising, digital innovation has the power to bring specialist-level insights into primary care in a whole new way,” said David Bates, PhD, CEO of Linus Health. “This launch is a major step in our mission to change the brain health outlook worldwide, which starts with supplying PCPs with new tools to bolster their efforts to protect their patients’ brain health.”  

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Alzheimer’s disease, Artificial Intelligence, dementia, digital innovation, healthcare delivery, PhD, Primary Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |